Literature DB >> 1993629

High dose preoperative irradiation for cancer of the rectum, 1976-1988.

M Mohiuddin1, G Marks.   

Abstract

Two hundred twenty patients with adenocarcinoma of the rectum have been treated in a program using high dose (greater than 4000 cGy) preoperative irradiation followed by radical surgical resection. The patients were staged on the basis of pretreatment clinical mobility of the cancers. Seventy-four patients had mobile cancers, 49 had partial fixation (tethered), 85 patients had total tumor fixation, and 12 patients had a frozen pelvis (unresectable). Patients were treated with high energy photons using a four field box technique with total doses ranging from 4000 to 6000 cGy. The overall incidence of local recurrence was 15% (32/220). Patients with fixed and unresectable tumors had a higher incidence of local recurrence, 20% (21/97) as compared with patients with mobile and partially fixed tumors, 10% (13/123). Local recurrence by pathological stage of disease was 6% for patients with Stages O, A, B1 versus 20% for patients with Stages B2 and C cancer. Overall 5-year survival of the total group was 67%. The 5-year survival by clinical stages of disease was 87% for mobile tumors, 74% for partially fixed tumors, 70% for fixed tumors, and 22% for the unresectable group. The 5-year survival by pathological stages of disease was 90% for those with Stage O, A, B1 and 71, 75, and 47%, respectively, for Stages B2, C1, and C2 disease.

Entities:  

Mesh:

Year:  1991        PMID: 1993629     DOI: 10.1016/0360-3016(91)90135-q

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Outcomes in 132 patients following laparoscopic total mesorectal excision (TME) for rectal cancer with greater than 5-year follow-up.

Authors:  John H Marks; Renee Huang; Dominique McKeever; Morgan Greenfield
Journal:  Surg Endosc       Date:  2015-04-24       Impact factor: 4.584

2.  Does preoperative radiation therapy enhance the probability of local control and survival in high-risk distal rectal cancer?

Authors:  W M Mendenhall; K I Bland; E M Copeland; G E Summers; W W Pfaff; W W Souba; R R Million
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

Review 3.  Radiation treatment for rectal cancer.

Authors:  B J Cummings
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy.

Authors:  Leyo Ruo; Satish Tickoo; David S Klimstra; Bruce D Minsky; Leonard Saltz; Madhu Mazumdar; Philip B Paty; W Douglas Wong; Steven M Larson; Alfred M Cohen; Jose G Guillem
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

5.  Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma.

Authors:  S Meterissian; J Skibber; T Rich; L Roubein; J Ajani; K Cleary; D M Ota
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

6.  Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum.

Authors:  R S Chari; D S Tyler; M S Anscher; L Russell; B M Clary; J Hathorn; H F Seigler
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

7.  Three cases with active bleeding from radiation enteritis that were diagnosed with video capsule endoscopy without retention.

Authors:  Masanao Nakamura; Yoshiki Hirooka; Osamu Watanabe; Takeshi Yamamura; Kazuhiro Furukawa; Kohei Funasaka; Eizaburo Ohno; Ryoji Miyahara; Hiroki Kawashima; Takafumi Ando; Naoki Ohmiya; Hidemi Goto
Journal:  Nagoya J Med Sci       Date:  2014-08       Impact factor: 1.131

8.  Induction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors.

Authors:  Sabrina Bimonte; Maddalena Leongito; Mauro Piccirillo; Maria Luisa Tamma; Marianna Vallifuoco; Adele Bracco; Antonio Mancini; Daniele Di Napoli; Sigismondo Castaldo; Santolo Cozzolino; Francesca Iacobellis; Roberto Grassi; Vincenza Granata; Secondo Lastoria; Steven Curley; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2016-12-01       Impact factor: 2.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.